TargTex
Joao Conde is currently the Vice-Dean for Research at NOVA Medical School - Faculdade de Ciências Médicas. In addition to their role at the medical school, Joao is also a Group Leader and Professor. Joao is involved in various scientific advisory boards and collaborations such as with the Fundação para a Ciência e a Tecnologia, the Institute for Health Metrics and Evaluation, and TargTex, where Joao is a Co-Founder. With a strong research background, Joao has held positions at prestigious institutions such as the Instituto de Medicina Molecular, Queen Mary University of London, Massachusetts Institute of Technology, and Universidade Nova de Lisboa. Joao completed their Doctor of Philosophy in Biology and NanoBiotechnology at Universidade Nova de Lisboa.
This person is not in any teams
TargTex
TargTex SA is a portuguese biotech company founded in 2019 that emerged from a blended academic research and medical environment. Its basic technology was developed in Gonçalo Bernardes research lab at Instituto de Medicina Molecular (iMM) of the University of Lisbon. Its foundation is based on an artificial intelligence algorithm created by one of the founding members that can decipher relationships between biological targets and molecules of interest. Hence, it was possible to identify an unexplored target for a daunting pathology – Glioblastoma (GBM). Considering GBM’s particularities, the company is developing a solution based on a hydrogel to be used as adjunct-to-surgery in a single dose therapy. On a long-term perspective, TargTex aims to develop clinical candidates for different oncological indications. The GBM pilot project is the first step to become a sustainable company that will enable the development of other anticancer candidates.